SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Caveat Emptor who wrote (301)7/27/1998 10:13:00 AM
From: Robert Holmes  Read Replies (2) of 410
 
CE,

This will be my last post to you. It is clear to me that your comments are disingenuous. I had a feeling in my last post that you'd offer some excuse why you wouldn't call Genzyme yourself.

As for your claims of profit taking. I can name countless companies, particularly during the period after the Asian crisis broke, that have large insider selling patterns. Genzyme's prospects are significantly better today than they have been for several years. Good luck on your shorted shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News